Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2017. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3316117017 | Atezolizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3316118010 | Atezolizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Atezolizumab (substance) | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Atezolizumab (substance) | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Atezolizumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Atezolizumab (substance) | Is a | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | true | Inferred relationship | Some | ||
| Atezolizumab (substance) | Has disposition (attribute) | Programmed cell death protein 1 inhibitor (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing atezolizumab (medicinal product) | Has active ingredient | True | Atezolizumab (substance) | Inferred relationship | Some | 1 |
| Product containing atezolizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Atezolizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only atezolizumab (medicinal product) | Has active ingredient | True | Atezolizumab (substance) | Inferred relationship | Some | 1 |
| Atezolizumab only product in parenteral dose form | Has active ingredient | True | Atezolizumab (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR